by MEGIN | Mar 31, 2020 | MEGIN News
HELSINKI, FINLAND (MARCH 31, 2020) – MEGIN is pleased to announce the sale of our fourth-generation technology, the TRIUX™ neo, to the Chinese Academy of Science (CAS)’s Institute of Neuroscience (ION). This is our second MEG sale to China in the last six months,...
by MEGIN | Mar 24, 2020 | MEGIN News
HELSINKI, FINLAND (MARCH 24, 2020) – MEGIN is pleased to announce the smooth and successful installation of the TRIUX neo at Cambridge University’s MRC Cognition and Brain Sciences Unit (CBU). In a display of exceptional teamwork between the the MEGIN and MRC CBU’s...
by MEGIN | Nov 21, 2019 | MEGIN News
HELSINKI, FINLAND (NOVEMBER 21, 2019) – Arkansas Children’s Hospital is now home to the TRIUX™ neo, the first and only magnetoencephalography system (MEG) in Arkansas. The TRIUX™ neo is MEGIN’s next generation of MEG technology which is used to detect and...
by MEGIN | Oct 9, 2019 | MEGIN News
HELSINKI, FINLAND (OCTOBER 9, 2019) – MEGIN is pleased to announce the sale of our fourth-generation technology, the TRIUX™ neo, to three internationally renowned neuroscience facilities. We are looking forward to working with the MRC Cognition and Brain Sciences...
by MEGIN | Dec 6, 2018 | MEGIN News
MEGIN CEO Speaks at Neuroscience-20 World Brain Mapping Summit in Argentina BUENOS AIRES, Argentina, Dec. 6, 2018 — Janne Huhtala, CEO of MEGIN, a manufacturer of magnetoencephalography (MEG) technology for functional brain imaging, spoke about the future...
by MEGIN | Sep 26, 2018 | MEGIN News
Click here to see the entire original article. “MEMPHIS, Tenn., Sept. 26, 2018/PRNewswire/ –MEGIN announced today Le Bonheur Children’s Hospital is the first hospital in the world to install TRIUX™ neo, the next generation of...
